Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Titan Medical completes public offering of US$3 million

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Octagon Capital Corporation

On March 14, 2012, Titan Medical Inc. (Titan) closed its previously announced public offering of units and raised gross proceeds of $3,000,000 to fund continued research and development with regard to Titan’s robotic surgical system platform and for working capital and general corporate expenses. The units were offered and sold under Titan’s previously filed amended and restated short form base shelf prospectus and pursuant to an agency agreement with Octagon Capital Corporation acting as exclusive agent for the offering. Octagon Capital Corporation was advised in this transaction by Stephen Erlichman, John Sabetti and Amira Abouali (securities) and Mitchell Thaw (tax) of Fasken Martineau.

Team

    Subscribe

    Receive email updates from our team

    Subscribe